All Stories

  1. Effects of functionalized silver nanoparticles on aggregation of human blood platelets

    Article • International Journal of Nanomedicine, September 2019, Taylor & Francis

    Professor Marek W Radomski, Nadhim Hante

  2. MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Iwona Bil-Lula, Professor Marek W Radomski, Joanna Urbaniak

  3. Sepsis-associated thrombocytopenia

    Article • Thrombosis Research, May 2016, Elsevier

    Professor Marek W Radomski

  4. Pharmacokinetics and bio-distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig

    Article • Clinical and Experimental Pharmacology and Physiology, February 2016, Wiley

    Professor Marek W Radomski

  5. Intestinal microbiota transplant – current state of knowledge

    Article • Reumatologia/Rheumatology, January 2016, Termedia Sp. z.o.o.

    Professor Marek W Radomski

  6. The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges

    Article • Advances in Clinical and Experimental Medicine, January 2016, Wroclaw Medical University

    Professor Marek W Radomski

  7. Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry

    Article • International Journal of Nanomedicine, August 2015, Dove Medical Press

    Professor Marek W Radomski, Dr Krzysztof A Tomaszewski, Professor Marek W Radomski

  8. CuO nanoparticles induce apoptosis by impairing the antioxidant defense and detoxification systems in the mouse hippocampal HT22 cell line: Protective effect of crocetin

    Article • Toxicology in Vitro, June 2015, Elsevier

    Professor Marek W Radomski

  9. Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS

    Article • Nanomedicine, June 2015, Future Medicine

    Professor Marek W Radomski

  10. Nanodiagnostics, nanopharmacology and nanotoxicology of platelet–vessel wall interactions

    Article • Nanomedicine, May 2015, Future Medicine

    Professor Marek W Radomski

  11. CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility

    Article • International Journal of Nanomedicine, April 2015, Taylor & Francis

    Professor Marek W Radomski, Dr Stephen Paul Samuel, Dr Namrata Jain, Professor Marek W Radomski

  12. Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells

    Article • International Journal of Nanomedicine, February 2015, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  13. Blood biocompatibility of surface-bound multi-walled carbon nanotubes

    Article • Nanomedicine Nanotechnology Biology and Medicine, January 2015, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  14. Magnetic Nanoparticles in Cancer Theranostics

    Article • Theranostics, January 2015, Ivyspring International Publisher

    Professor Marek W Radomski

  15. Pegylation Increases Platelet Biocompatibility of Gold Nanoparticles

    Article • Journal of Biomedical Nanotechnology, June 2014, American Scientific Publishers

    Professor Marek W Radomski, Professor Justin D Holmes, Professor Marek W Radomski

  16. Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride

    Article • International Journal of Nanomedicine, April 2014, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  17. Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance

    Article • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, March 2014, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  18. Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

    Article • European Journal of Cancer, May 2013, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  19. Platelets and photodynamic cancer therapy

    Article • Photodiagnosis and Photodynamic Therapy, February 2013, Elsevier

    Professor Mathias O. Senge, Professor Marek W Radomski, Professor Marek W Radomski

  20. Nanoparticle Adhesion to the Cell Membrane and Its Effect on Nanoparticle Uptake Efficiency

    Article • Journal of the American Chemical Society, January 2013, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  21. MMP inhibition by barbiturate homodimers

    Article • Bioorganic & Medicinal Chemistry Letters, January 2013, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  22. Targeted Delivery of Transferrin-Conjugated Liposomes to an Orthotopic Model of Lung Cancer in Nude Rats

    Article • Journal of Aerosol Medicine and Pulmonary Drug Delivery, December 2012, Mary Ann Liebert Inc

    Professor Marek W Radomski, Professor Marek W Radomski

  23. Mechanisms of Toxicity of Amorphous Silica Nanoparticles on Human Lung Submucosal Cells in Vitro: Protective Effects of Fisetin

    Article • Chemical Research in Toxicology, September 2012, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  24. Approaches to the safety assessment of engineered nanomaterials (ENM) in food

    Article • Food and Chemical Toxicology, June 2012, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  25. Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin

    Article • British Journal of Pharmacology, May 2012, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  26. Fisetin prevents fluoride- and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells

    Article • Food and Chemical Toxicology, March 2012, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  27. Design of Barbiturate–Nitrate Hybrids that Inhibit MMP-9 Activity and Secretion

    Article • Journal of Medicinal Chemistry, February 2012, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  28. Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis

    Article • International Journal of Nanomedicine, February 2012, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  29. The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation

    Article • International Journal of Nanomedicine, January 2012, Taylor & Francis

    Professor Marek W Radomski, Professor Justin D Holmes, Professor Marek W Radomski, Professor Hongzhou Zhang

  30. Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets

    Article • Journal of Pharmacy and Pharmacology, November 2011, Oxford University Press (OUP)

    Professor Marek W Radomski, Professor Marek W Radomski

  31. N-Substituted homopiperazine barbiturates as gelatinase inhibitors

    Article • Bioorganic & Medicinal Chemistry, August 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  32. NOVEL DUAL NITRIC OXIDE RELEASING ANTI-REMODELING THERAPY FOR HYPERTENSIVE HEART DISEASE

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  33. SUPERASPIRINS: NOVEL PRO-DRUGS ARE MORE EFFECTIVE THAN CONVENTIONAL ASPIRIN AND DO NOT CAUSE DIRECT GI TOXICITY

    Article • Journal of the American College of Cardiology, April 2011, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  34. Analysis of platelet function: role of microfluidics and nanodevices

    Article • The Analyst, January 2011, Royal Society of Chemistry

    Professor Marek W Radomski, Professor Marek W Radomski

  35. Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling

    Article • January 2011, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  36. Isosorbide-Based Aspirin Prodrugs: Integration of Nitric Oxide Releasing Groups

    Article • Journal of Medicinal Chemistry, October 2009, American Chemical Society (ACS)

    Professor Marek W Radomski, Professor Marek W Radomski

  37. Platelet compatibility of PLGA, chitosan and PLGA–chitosan nanoparticles

    Article • Nanomedicine, October 2009, Future Medicine

    Professor Marek W Radomski, Professor Marek W Radomski

  38. NANOINTERACT: A rational approach to the interaction between nanoscale materials and living matter?

    Article • Journal of Physics Conference Series, May 2009, Institute of Physics Publishing

    Prof. Iseult Lynch, Professor Marek W Radomski, Professor Marek W Radomski

  39. A differential release of matrix metalloproteinases 9 and 2 during coronary artery bypass grafting and off-pump coronary artery bypass surgery

    Article • Journal of Thoracic and Cardiovascular Surgery, May 2009, Elsevier

    Professor Marek W Radomski, Dr Ewa Jędrzejczyk-Patej, Professor Marek W Radomski

  40. Characterisation of the R3/1 cell line as an alveolar epithelial cell model for drug disposition studies

    Article • European Journal of Pharmaceutical Sciences, March 2009, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  41. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK

    Article • Cell Cycle, November 2008, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  42. Role of metalloproteinases in platelet function

    Article • Thrombosis Research, January 2008, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  43. Nanoparticles: pharmacological and toxicological significance

    Article • British Journal of Pharmacology, March 2007, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  44. Selectins – potential pharmacological targets?

    Article • Drug Discovery Today, November 2006, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  45. Increased Alveolar and Plasma Gelatinases Activity during Postpump Syndrome: Inhibition by Inhaled Nitric Oxide

    Article • Journal of Cardiovascular Pharmacology, September 2006, Wolters Kluwer Health

    Professor Marek W Radomski, Pr Eric Troncy, Professor Marek W Radomski

  46. Platelet Dysfunction in Asphyxiated Newborn Piglets Resuscitated with 21% and 100% Oxygen

    Article • Pediatric Research, May 2006, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  47. Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients

    Article • Neuropsychopharmacology, November 2005, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  48. Nanoparticle‐induced platelet aggregation and vascular thrombosis

    Article • British Journal of Pharmacology, November 2005, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  49. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study

    Article • Journal of Thoracic and Cardiovascular Surgery, April 2005, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  50. Platelet–leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases

    Article • British Journal of Pharmacology, December 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  51. Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation

    Article • British Journal of Pharmacology, December 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  52. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder

    Article • Biological Psychiatry, July 2004, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  53. Membrane type‐1 matrix metalloproteinase stimulates tumour cell‐induced platelet aggregation: role of receptor glycoproteins

    Article • British Journal of Pharmacology, January 2004, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  54. Release of matrix metalloproteinase-9 during balloon angioplasty in patients with stable angina.

    Article • International Journal of Cardiology, December 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  55. Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger

    Article • Journal of Thoracic and Cardiovascular Surgery, March 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  56. Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study

    Article • Thrombosis Research, January 2003, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  57. Identification, regulation and role of tissue inhibitor of metalloproteinases‐4 (TIMP‐4) in human platelets

    Article • British Journal of Pharmacology, December 2002, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  58. Mechanisms of action of proteinase‐activated receptor agonists on human platelets

    Article • British Journal of Pharmacology, March 2002, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  59. Role of von Willebrand factor in tumour cell‐induced platelet aggregation: differential regulation by NO and prostacyclin

    Article • British Journal of Pharmacology, November 2001, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  60. Pharmacological characteristics of solid‐phase von Willebrand factor in human platelets

    Article • British Journal of Pharmacology, November 2001, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  61. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts

    Article • Journal of Thoracic and Cardiovascular Surgery, October 2001, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  62. Effects of LY117018 and the Estrogen Analogue, 17α-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric Oxide

    Article • Journal of Cardiovascular Pharmacology, January 2001, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  63. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates

    Article • Critical Care Medicine, July 2000, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  64. Inhmition of matrix metalloproteinases(MMPs)prevents tissue injury and fibrotic complications in two rat models of inflammatory bowel disease

    Article • Gastroenterology, April 2000, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  65. Nitric Oxide and Platelet Function

    Article • January 2000, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  66. Regulation of Platelet Function

    Article • January 2000, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  67. The role of nitric oxide in the regulation of ion channels in airway epithelium: Implications for diseases of the lung

    Article • Free Radical Research, January 2000, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  68. Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by S-nitrosoglutathione

    Article • Journal of Thoracic and Cardiovascular Surgery, May 1999, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  69. Differential Inhibition of Platelet Aggregation by Indomethacin and Inhaled Nitric Oxide in Critically Ill Infants

    Article • Pediatric Research, April 1999, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  70. NO effect on hemostasis

    Article • The Journal of Pediatrics, March 1999, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  71. Nitric Oxide-Mediated Regulation of Platelet Function

    Article • January 1999, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  72. The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia‐induced lung injury in newborn rats

    Article • British Journal of Pharmacology, December 1998, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  73. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin‐resistant, obese JCR:LA‐cp rats

    Article • British Journal of Pharmacology, May 1998, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  74. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates

    Article • The Lancet, April 1998, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  75. Nitric oxide: Implications for placental biology

    Article • Placenta, January 1998, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  76. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance

    Article • Canadian Journal of Physiology and Pharmacology, January 1998, Canadian Science Publishing

    Professor Marek W Radomski

  77. Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance

    Article • Canadian Journal of Physiology and Pharmacology, January 1998, Canadian Science Publishing

    Professor Marek W Radomski

  78. Nitric oxide and platelet function: Implications for neonatology

    Article • Seminars in Perinatology, October 1997, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  79. Release of gelatinase A during platelet activation mediates aggregation

    Article • Nature, April 1997, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  80. Regulation of Platelet Function by Nitric Oxide

    Article • January 1997, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  81. Nitric oxide: Implications for placental biology

    Article • Placenta, July 1996, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  82. [9] Nitric oxide in platelets

    Article • January 1996, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  83. Nitric oxide— biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis

    Article • Atherosclerosis, December 1995, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  84. The formation of nitric oxide donors from peroxynitrite

    Article • British Journal of Pharmacology, October 1995, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  85. Biological Significance of Nitric Oxide

    Article • Physiological Zoology, July 1995, University of Chicago Press

    Professor Marek W Radomski

  86. Nitric Oxide: Biological Mediator, Modulator and Effector

    Article • Annals of Medicine, January 1995, Taylor & Francis

    Professor Marek W Radomski, Professor Marek W Radomski

  87. Nitric oxide donors inhibit platelet spreading on surfaces coated with fibrinogen but not with fibronectin

    Article • Thrombosis Research, September 1994, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski, Prof Maria Angeles Moro

  88. Nitric oxide in the clinical arena

    Article • Journal of Hypertension, June 1994, Wolters Kluwer Health

    Professor Marek W Radomski, Professor Marek W Radomski

  89. Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase

    Article • British Journal of Pharmacology, April 1993, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  90. The Biological and Pharmacological Role of Nitric Oxide in Platelet Function

    Article • January 1993, Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  91. S‐nitroso‐glutathione inhibits platelet activation in vitro and in vivo

    Article • British Journal of Pharmacology, November 1992, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  92. Modulation of platelet aggregation by an l-arginine-nitric oxide pathway

    Article • Trends in Pharmacological Sciences, January 1991, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  93. Endothelium-derived relaxing factor

    Article • Biochemical Pharmacology, July 1988, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  94. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium

    Article • Biochemical and Biophysical Research Communications, November 1987, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  95. Inhibition of human platelet aggregation by vitamin K

    Article • Thrombosis Research, January 1985, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  96. Prostacyclin prolongs viability of washed human platelets

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, September 1982, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  97. Conversion of exogenous arachidonic acid to prostaglandins in the pulmonary circulation in vivo A human and animal study

    Article • Acta Physiologica Scandinavica, August 1981, Wiley

    Professor Marek W Radomski, Professor Marek W Radomski

  98. Angiotensin-induced release of prostacyclin (PGI2) into circulation of anaesthetized cats

    Article • Pharmacological Research Communications, September 1979, Elsevier

    Professor Marek W Radomski, Professor Marek W Radomski

  99. Nitric Oxide, Platelet Function, Myocardial Infarction and Reperfusion Therapies

    Article • Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski

  100. The Nitric Oxide-Endothelin-1 Connection

    Article • Springer Science + Business Media

    Professor Marek W Radomski, Professor Marek W Radomski